创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

卢懿, 黄味子, 戚建平, 吴伟. 杂化纳米结晶及其体内命运研究进展[J]. 药学进展, 2020, 44(5): 342-350.
引用本文: 卢懿, 黄味子, 戚建平, 吴伟. 杂化纳米结晶及其体内命运研究进展[J]. 药学进展, 2020, 44(5): 342-350.
LU Yi, HUANG Weizi, QI Jianping, WU Wei. Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 342-350.
Citation: LU Yi, HUANG Weizi, QI Jianping, WU Wei. Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate[J]. Progress in Pharmaceutical Sciences, 2020, 44(5): 342-350.

杂化纳米结晶及其体内命运研究进展

Advances in the Research on Hybrid Nanocrystal and Its In Vivo Fate

  • 摘要: 纳米结晶在难溶性药物的递送方面具有重要的应用前景,但人们对其作用机制仍所知有限。通过物理嵌入方式制备的杂化荧光探针纳米结晶,为体内示踪提供了强有力的工具。在简要介绍当前纳米结晶体内命运研究进展的基础上,详细介绍了杂化纳米结晶的基本概念、制备方法及技术发展历程,重点阐述基于聚集导致淬灭荧光探针的纳米结晶技术,以及由此获得的纳米结晶经口服、注射和滴眼给药的体内命运。

     

    Abstract: Nanocrystals are promising in the delivery of poorly water-soluble drugs. However, information on the in vivo performance of nanocrystals is still not well understood. Physically embedded fluorophores in crystal lattice, i.e. the hybrid nanocrystals, enable bioimaging of nanocrystals. After a brief introduction to the up-to-date approaches to explore in vivo fates of nanocrystals, this article details the theoretical concepts as well as the techniques for the preparation and development of hybrid nanocrystals. Particular attention was paid to hybrid nanocrystals based on aggregation-caused quenching fluorescent probes as well as in vivo fates of nanocrystals via oral, intravenous and ocular routes obtained through this technique.

     

/

返回文章
返回